Medinova Diagnostic Services Limited (BOM:526301)
India · Delayed Price · Currency is INR 40.71
-0.18 (-0.44%)
At close: Sep 1, 2025
BOM:526301 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Operating Revenue | 100.44 | 98.13 | 101.65 | 99.93 | 132.02 | 127.44 | Upgrade |
| 100.44 | 98.13 | 101.65 | 99.93 | 132.02 | 127.44 | Upgrade | |
Revenue Growth (YoY) | -1.91% | -3.47% | 1.72% | -24.31% | 3.60% | 71.12% | Upgrade |
Cost of Revenue | 31.77 | 39.49 | 41.87 | 43.67 | 69.22 | 72.21 | Upgrade |
Gross Profit | 68.67 | 58.64 | 59.78 | 56.26 | 62.8 | 55.23 | Upgrade |
Selling, General & Admin | - | 5.81 | 5.73 | 5.13 | 2.42 | 1.94 | Upgrade |
Other Operating Expenses | 35.1 | 22.87 | 26.23 | 25.12 | 23.32 | 23.73 | Upgrade |
Operating Expenses | 36.57 | 30.13 | 33.23 | 33.51 | 31.2 | 32.84 | Upgrade |
Operating Income | 32.1 | 28.51 | 26.55 | 22.74 | 31.6 | 22.39 | Upgrade |
Interest Expense | -4.94 | -5 | -5.74 | -5.99 | -5.09 | -4.13 | Upgrade |
Interest & Investment Income | - | 0.94 | 0.35 | 0.31 | 0.4 | 1.23 | Upgrade |
Other Non Operating Income (Expenses) | 1.85 | 0.39 | 1.63 | 1.94 | 1.07 | 0.13 | Upgrade |
EBT Excluding Unusual Items | 29.02 | 24.84 | 22.79 | 19 | 27.97 | 19.62 | Upgrade |
Gain (Loss) on Sale of Investments | - | 0.13 | - | - | - | - | Upgrade |
Pretax Income | 29.02 | 24.97 | 22.79 | 19 | 27.97 | 19.62 | Upgrade |
Income Tax Expense | 7.67 | 6 | 2.8 | 2.35 | 4.16 | 0.58 | Upgrade |
Earnings From Continuing Operations | 21.35 | 18.97 | 19.99 | 16.65 | 23.81 | 19.05 | Upgrade |
Minority Interest in Earnings | - | - | - | - | -1.12 | 1.17 | Upgrade |
Net Income | 21.35 | 18.97 | 19.99 | 16.65 | 22.68 | 20.22 | Upgrade |
Net Income to Common | 21.35 | 18.97 | 19.99 | 16.65 | 22.68 | 20.22 | Upgrade |
Net Income Growth | 2.24% | -5.11% | 20.04% | -26.58% | 12.17% | - | Upgrade |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 10 | Upgrade |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 10 | Upgrade |
Shares Change (YoY) | 0.38% | - | - | - | - | - | Upgrade |
EPS (Basic) | 2.13 | 1.90 | 2.00 | 1.67 | 2.27 | 2.03 | Upgrade |
EPS (Diluted) | 2.13 | 1.89 | 2.00 | 1.67 | 2.27 | 2.03 | Upgrade |
EPS Growth | 1.85% | -5.50% | 19.89% | -26.51% | 12.05% | - | Upgrade |
Free Cash Flow | - | 20.16 | 24.51 | 10.32 | 11.83 | 15 | Upgrade |
Free Cash Flow Per Share | - | 2.02 | 2.46 | 1.03 | 1.19 | 1.50 | Upgrade |
Gross Margin | 68.37% | 59.76% | 58.81% | 56.29% | 47.57% | 43.34% | Upgrade |
Operating Margin | 31.96% | 29.05% | 26.12% | 22.76% | 23.94% | 17.57% | Upgrade |
Profit Margin | 21.26% | 19.33% | 19.66% | 16.66% | 17.18% | 15.87% | Upgrade |
Free Cash Flow Margin | - | 20.55% | 24.11% | 10.33% | 8.96% | 11.77% | Upgrade |
EBITDA | 33.64 | 29.79 | 27.63 | 25.98 | 37.04 | 29.56 | Upgrade |
EBITDA Margin | 33.49% | 30.35% | 27.18% | 25.99% | 28.06% | 23.19% | Upgrade |
D&A For EBITDA | 1.54 | 1.28 | 1.08 | 3.23 | 5.44 | 7.17 | Upgrade |
EBIT | 32.1 | 28.51 | 26.55 | 22.74 | 31.6 | 22.39 | Upgrade |
EBIT Margin | 31.96% | 29.05% | 26.12% | 22.76% | 23.94% | 17.57% | Upgrade |
Effective Tax Rate | 26.42% | 24.03% | 12.29% | 12.36% | 14.88% | 2.93% | Upgrade |
Revenue as Reported | 102.29 | 99.59 | 103.63 | 102.18 | 133.48 | 128.8 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.